From Protein-Protein Interactions to Rational Drug Design: Are Computational Methods Up to the Challenge?



The study of protein-protein interactions (PPIs) has been growing for some years now, mainly as a result of easy access to high-throughput experimental data. Several computational approaches have been presented throughout the years as means to infer PPIs not only within the same species, but also between different species (e.g., host-pathogen interactions). The importance of unveiling the human protein interaction network is undeniable, particularly in the biological, biomedical and pharmacological research areas. Even though protein interaction networks evolve over time and can suffer spontaneous alterations, occasional shifts are often associated with disease conditions. These disorders may be caused by external pathogens, such as bacteria and viruses, or by intrinsic factors, such as auto-immune disorders and neurological impairment. Therefore, having the knowledge of how proteins interact with each other will provide a great opportunity to understand pathogenesis mechanisms, and subsequently support the development of drugs focused on very specific disease pathways and re-targeting already commercialized drugs to new gene products. Computational methods for PPI prediction have been highlighted as an interesting option for interactome mapping. In this paper we review the techniques and strategies used for both experimental identification and computational inference of PPIs. We will then discuss how this knowledge can be used to create protein interaction networks (PINs) and the various methodologies applied to characterize and predict the so-called “disease genes” and “disease networks”. This will be followed by an overview of the strategies employed to predict drug targets.


Disease networks; Drug design; Drug targets; Protein-Protein interaction




Current Topics in Medicinal Chemistry, Vol. 13, #5, pp. 602-618, Bentham Science Publishers, March 2013


Cited by

Year 2017 : 1 citations

 Leney, Aneika C., and Albert JR Heck. "Native Mass Spectrometry: What is in the Name?." Journal of The American Society for Mass Spectrometry 28.1 (2017): 5-13.

Year 2016 : 1 citations

 Roukos, Dimitrios H. "Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapies." Drug discovery today 21.4 (2016): 663-673.

Year 2015 : 4 citations

 Sable, Rushikesh, and Seetharama Jois. "Surfing the protein-protein interaction surface using docking methods: application to the design of PPI inhibitors." Molecules 20.6 (2015): 11569-11603.\

 Coelho, Edgar D., et al. "Computational methodology for predicting the landscape of the human–microbial interactome region level influence." Journal of bioinformatics and computational biology 13.05 (2015): 1550023.

 Coelho, Edgar D., Joel P. Arrais, and José Luís Oliveira. "Uncovering microbial duality within human microbiomes: A novel algorithm for the analysis of host-pathogen interactions." Engineering in Medicine and Biology Society (EMBC), 2015 37th Annual International Conference of the IEEE. IEEE, 2015.

 Zhu, Fei, et al. "Protein-protein interaction network constructing based on text mining and reinforcement learning with application to prostate cancer." Trustcom/BigDataSE/ISPA, 2015 IEEE. Vol. 1. IEEE, 2015.

Year 2014 : 1 citations

 Soares, André do Nascimento Gonçalves. Interatómica da cavidade oral. Diss. Universidade Católica Portuguesa, 2014.

Year 2013 : 2 citations

 Baaden, Marc, and Siewert J. Marrink. "Coarse-grain modelling of protein–protein interactions." Current opinion in structural biology 23.6 (2013): 878-886.

 Huang, Sui, and Stuart Kauffman. "How to escape the cancer attractor: rationale and limitations of multi-target drugs." Seminars in cancer biology. Vol. 23. No. 4. Academic Press, 2013.